<SUBMISSION>
<SECRELEASE-DATETIME> 20160325-080212 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME> 20160325-080212 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME> 20160325-080132 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER> 0001193125-16-517645
<TYPE> DEF 14A
<PUBLIC-DOCUMENT-COUNT> 2
<PERIOD> 20160505
<FILING-DATE> 20160325
<DATE-OF-FILING-DATE-CHANGE> 20160325
<EFFECTIVENESS-DATE> 20160325
|
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME> Opko Health, Inc.
<CIK> 0000944809
<ASSIGNED-SIC> 2834
<IRS-NUMBER> 752402409 ⇒ 75-2402409
<STATE-OF-INCORPORATION> DE
<FISCAL-YEAR-END> 1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE> DEF 14A
<ACT> 34
<FILE-NUMBER> 001-33528
<FILM-NUMBER> 161528803
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1> 4400 BISCAYNE BLVD.
<CITY> MIAMI
<STATE> FL
<ZIP> 33137
<PHONE> 305-575-4138
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1> 4400 BISCAYNE BLVD.
<CITY> MIAMI
<STATE> FL
<ZIP> 33137
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> eXegenics Inc
<DATE-CHANGED> 20040505
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> EXEGENICS INC
<DATE-CHANGED> 20011114
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME> CYTOCLONAL PHARMACEUTICS INC /DE
<DATE-CHANGED> 19950503
</FORMER-COMPANY>
</FILER>
|
<DOCUMENT>
<TYPE> DEF 14A
<SEQUENCE> 1
<FILENAME> d114213ddef14a.htm
<DESCRIPTION> DEF 14A
<TEXT>
<HTML>
Show <HTML>: 5,074 lines (widest: 249 characters) - 493K bytes
</TEXT>
</DOCUMENT>
|
<DOCUMENT>
<TYPE> GRAPHIC
<SEQUENCE> 2 ⇐ Not a Document/Exhibit
<FILENAME> g114213image002.jpg
<DESCRIPTION> GRAPHIC
<TEXT>
Show <TEXT>: 74 lines (Unix-to-Unix encoding) - 5K bytes
</TEXT>
</DOCUMENT>
|
</SUBMISSION> |
| ↑Top |
